SciSparc (SPRC) director discloses shares, options and RSU awards
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
SciSparc Ltd. director Shrem Itschak filed an initial ownership report showing his equity position in the company. He directly holds 11,058 Ordinary Shares and a stock option to buy 6 Ordinary Shares at an exercise price of 21294.0000 per share, expiring on March 1, 2028.
The filing also notes restricted share units. These include 10,000 Ordinary Shares in RSUs vesting in equal quarterly installments of 1,250 shares beginning on March 18, 2026, and 396 Ordinary Shares in RSUs vesting 50 shares quarterly beginning on September 30, 2024. Each RSU converts into one Ordinary Share when vested.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Shrem Itschak
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock option (right to buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Stock option (right to buy) — 6 shares (Direct);
Ordinary Shares — 11,058 shares (Direct)
Footnotes (1)
- Includes (i) 10,000 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares") issuable upon the vesting of restricted share units ("RSUs") in equal quarterly installments of 1,250 Ordinary Shares beginning on March 18, 2026; and (ii) 396 Ordinary Shares issuable upon the vesting of RSUs in equal quarterly installments of 50 Ordinary Shares beginning on September 30, 2024. Each RSU represents the right to receive one Ordinary Share. Fully vested on April 21, 2024.
FAQ
What does SciSparc (SPRC) director Shrem Itschak report owning in this Form 3?
Director Shrem Itschak reports direct ownership of 11,058 Ordinary Shares of SciSparc Ltd. He also reports a stock option for 6 Ordinary Shares and multiple restricted share unit grants that may convert into additional shares as they vest over time.
What stock option position does Shrem Itschak hold in SciSparc (SPRC)?
He holds a stock option to buy 6 Ordinary Shares of SciSparc at an exercise price of 21294.0000 per share. This option became fully vested on April 21, 2024 and is scheduled to expire on March 1, 2028.
Is this SciSparc (SPRC) Form 3 a buy or sell transaction by Shrem Itschak?
This Form 3 is an initial statement of beneficial ownership, not a buy or sell report. It lists the director’s existing holdings in Ordinary Shares, stock options, and RSUs as of the reporting date, without showing any new purchase or sale transactions.
How long do Shrem Itschak’s SciSparc (SPRC) stock options remain exercisable?
The disclosed stock option relating to 6 Ordinary Shares was fully vested by April 21, 2024 and carries an expiration date of March 1, 2028. After that expiration date, any unexercised portion would no longer be available to exercise.
When do the RSUs reported by SciSparc (SPRC) director Shrem Itschak start vesting?
Two RSU schedules are reported. 396 Ordinary Shares in RSUs begin vesting in 50-share quarterly installments on September 30, 2024. Another 10,000 Ordinary Shares in RSUs vest in 1,250-share quarterly installments beginning on March 18, 2026, each RSU delivering one Ordinary Share.